oc-dc
Vaccineexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2010 (NCT01132014)
Timeline
2010s
- Jan 1, 2010
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Tumor antigensImmunity, active
immunity, active - tumor antigens
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- oc-dc
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05714306 | Phase 1/Phase 2 (Phase 2) | Jun 30, 2023 | University of Lausanne |
| NCT01312376 | Phase 1 | Mar 1, 2011 | University of Pennsylvania |
| NCT01132014 | Early Phase 1 (Phase 1) | May 1, 2010 | University of Pennsylvania |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Pennsylvania | Academic/Hospital | 2 | 2 | 1 | 2010 |
| University of Lausanne | Academic/Hospital | 1 | 1 | 1 | 2023 |
2 organizations
Page 1 / 1